Cenobamate Monotherapy for Focal Epilepsy
Cenobamate monotherapy was found to significantly reduce seizure frequency and achieve high seizure freedom rates and was well tolerated in patients with focal epilepsy, highlighting its promise as an emerging alternative for patients with refractory focal epilepsy.
Authors
- Andrea Gil Guevara
- E. Zengin (ORCID: https://orcid.org/0000-0002-8213-2845)
- Fred A. Lado (ORCID: https://orcid.org/0000-0003-3648-4812)
- Ferhat Erol (ORCID: https://orcid.org/0000-0002-1519-2928)
Institutions
- Hofstra University (US)
- North Shore University Hospital (US)
Publication Details
- Journal
- Neurology Clinical Practice
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1212/cpj.0000000000200460
- Citations
- 3
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.41